Initial PrEP product choice: results from the HPTN 084 open-label extension

被引：0

作者：

Delany-Moretlwe, S. ^{[1
]}

Hanscom, B. ^{[2
]}

Angira, F. ^{[3
]}

Dadabhai, S. ^{[4
]}

Gadama, D. ^{[5
]}

Mirembe, B. ^{[6
]}

Bhondai, M.

Innes, S. ^{[8
]}

Kalonji, D. ^{[9
]}

Makhema, J. ^{[10
]}

Mandima, P. ^{[7
]}

Marais, A. ^{[11
]}

Mpendo, J. ^{[12
]}

Mukwekwerere, P. ^{[7
]}

Mgodi, N.

Naidoo, V. ^{[13
]}

Ntege, P. Nahirya ^{[14
]}

Nuwagaba-Biribonwoha, H. ^{[15
]}

Roos, E. ^{[1
]}

Singh, N. ^{[16
]}

Siziba, B. ^{[7
]}

Spooner, E.

Farrior, J. ^{[17
]}

Rose, S. ^{[17
]}

Piwowar-Manning, E. ^{[18
]}

Burton, M. ^{[19
]}

Soto-Torres, L. ^{[20
]}

Rooney, J. ^{[21
]}

Rinehart, A. ^{[22
]}

Cohen, M.

Hosseinipour, M. ^{[23
,24
]}

机构：

[1] Univ Witwatersrand, Wits RHI, Johannesburg, South Africa

[2] Fred Hutchinson Canc Res Inst, Stat Ctr HIV AIDS Res Prevent, Seattle, WA USA

[3] KEMRI, Kisumu, Kenya

[4] Coll Med Blanytre, Blantyre, Malawi

[5] UNC Project Malawi, Lilongwe, Malawi

[6] Johns Hopkins Univ Res Collaborat, Makerere Univ, Kampala, Uganda

[7] Univ Zimbabwe, Clin Trials Res Ctr, Harare, Zimbabwe

[8] Desmond Tutu Hlth Fdn, Cape Town, South Africa

[9] South African Med Res Council, HIV & Other Infect Dis Res Unit, Durban, South Africa

[10] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana

[11] Univ Witwatersrand, Perinatal HIV Res Unit, Soweto, South Africa

[12] UVRI IAVI, Entebbe, Uganda

[13] Univ Stellenbosch, Desmond Tutu TB Ctr, Stellenbosch, South Africa

[14] Baylor Coll Med, Childrens Fdn Uganda, Kampala, Uganda

[15] Columbia Univ, Mailman Sch Publ Hlth, Eswatini Prevent Ctr, Mbabane, South Africa

[16] South African Med Res Council, Durban, South Africa

[17] FHI360, Durham, NC USA

[18] Johns Hopkins Univ, Sch Med, Baltimore, MD USA

[19] Fred Hutchinson Canc Res Inst, Seattle, WA USA

[20] NIAID, Rockville, MD USA

[21] Gilead Sci, Foster City, CA USA

[22] ViiV Healthcare, Durham, NC USA

[23] Univ North Carolina Chapel Hill, Chapel Hill, NC USA

[24] UNC Project Malawi, Lilongwe, Malawi

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2023年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

OALBX0203

引用

页数：2

共 50 条

[41] PASADENA 1-year Open-label Extension [J].

Pagano, G. ;

Reyes, A. ;

Monnet, A. ;

Martinec, M. ;

Shariati, N. ;

Simuni, T. ;

Marek, K. ;

Postuma, R. ;

Pavese, N. ;

Stocchi, F. ;

Taylor, K. ;

Svoboda, H. ;

Fontoura, P. ;

Kerchner, G. ;

Doody, R. ;

Bonni, A. ;

Nikolcheva, T. .

MOVEMENT DISORDERS, 2023, 38 :S44-S44

[42] LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY [J].

Banerji, A. ;

Hao, J. ;

Yu, M. ;

Bernstein, J. ;

Johnston, D. ;

Riedl, M. .

ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (05) :S21-S21

[43] Long-term effects of evolocumab in participants with HIV and dyslipidemia: results from the open-label extension period [J].

Boccara, Franck ;

Caramelli, Bruno ;

Calmy, Alexandra ;

Kumar, Princy ;

Lopez, J. Antonio G. ;

Bray, Sarah ;

Cyrille, Marcoli ;

Rosenson, Robert S. .

AIDS, 2022, 36 (05) :675-682

[44] Open-label extension studies: Interpretation and statistical issues [J].

Weatherall M. ;

Burgess C. ;

Taylor W. .

International Journal of Pharmaceutical Medicine, 2007, 21 (2) :115-120

[45] When Should Open-Label Extension Studies Be Stopped? [J].

Crites, Joshua S. .

AMERICAN JOURNAL OF BIOETHICS, 2014, 14 (04) :57-58

[46] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework [J].

Amico, K. Rivet ;

Wallace, Melissa ;

Bekker, Linda-Gail ;

Roux, Surita ;

Atujuna, Millicent ;

Sebastian, Elaine ;

Dye, Bonnie J. ;

Elharrar, Vanessa ;

Grant, Robert M. .

AIDS AND BEHAVIOR, 2017, 21 (05) :1361-1375

[47] Experiences with HPTN 067/ADAPT Study-Provided Open-Label PrEP Among Women in Cape Town: Facilitators and Barriers Within a Mutuality Framework [J].

K. Rivet Amico ;

Melissa Wallace ;

Linda-Gail Bekker ;

Surita Roux ;

Millicent Atujuna ;

Elaine Sebastian ;

Bonnie J. Dye ;

Vanessa Elharrar ;

Robert M. Grant .

AIDS and Behavior, 2017, 21 :1361-1375

[48] Eculizumab monotherapy for NMOSD: Data from PREVENT and its open-label extension [J].

Pittock, Sean J. ;

Fujihara, Kazuo ;

Palace, Jacqueline ;

Berthele, Achim ;

Kim, Ho Jin ;

Oreja-Guevara, Celia ;

Nakashima, Ichiro ;

Levy, Michael ;

Shang, Shulian ;

Yountz, Marcus ;

Miller, Larisa ;

Armstrong, Roisin ;

Wingerchuk, Dean M. .

MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (03) :480-486

[49] Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents [J].

Hagerman, Randi ;

Jacquemont, Sebastien ;

Berry-Kravis, Elizabeth ;

Des Portes, Vincent ;

Stanfield, Andrew ;

Koumaras, Barbara ;

Rosenkranz, Gerd ;

Murgia, Alessandra ;

Wolf, Christian ;

Apostol, George ;

von Raison, Florian .

SCIENTIFIC REPORTS, 2018, 8

[50] Mavoglurant in Fragile X Syndrome: Results of two open-label, extension trials in adults and adolescents [J].

Randi Hagerman ;

Sebastien Jacquemont ;

Elizabeth Berry-Kravis ;

Vincent Des Portes ;

Andrew Stanfield ;

Barbara Koumaras ;

Gerd Rosenkranz ;

Alessandra Murgia ;

Christian Wolf ;

George Apostol ;

Florian von Raison .

Scientific Reports, 8

← 1 2 3 4 5 →